The drug giant, which is headquartered in London, will use Infosys to support manufacturing, supply chain, finance, human resources and other applications.
The company has outsourced large amounts of its IT infrastructure. In 2007, it signed a £832 million deal with IBM to provide email, hosting, networking, PC management, server, storage and service management support.
AstraZeneca also signed a £47 million outsourcing deal with Cognizant in March 2008 for centralised data management services.
Commenting on the Infosys deal, Richard Williams, global CIO at AstraZeneca said: "We chose Infosys as a strategic partner for its understanding of the rapidly shifting dynamics in the pharmaceutical industry."
"Infosys’ outsourcing expertise, technology leadership and proven record in rationalising and standardising business process were all contributing factors to our decision,” he added.
Under the contract, Infosys will deliver services through a global shared-services model that offers “fixed price for outcome-based deliverables, and flexible, unit pricing for managing changes in the base scope of the engagement,” the outsourcer said.
The business model aims to give AstraZeneca greater operational flexibility, lower risk and better spend control. AstraZeneca expects to see improved asset use, standardised business processes, globally consistent service quality and a predicable cost structure. Some AstraZeneca employees in Sweden and the UK will be “rebadged” to Infosys.